Top Markets
Coin of the day
Eli Lilly Eli Lilly

Eli Lilly

LLY
Rank in Stocks #14
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Share Price
$885.05
Market Cap
$836.21B
Change (1 day)
0.77%
Change (1 year)
22.29%
Country
US
Trade Eli Lilly (LLY)

Category

Price of LLY with the market cap of B
Eli Lilly Eli Lilly
LLY
$885.05
Market Capitalization of Eli Lilly(LLY)
Market Cap: $836.21B
As of April 2026 Eli Lilly has a market cap of $836.21B. This makes Eli Lilly the world's 14th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eli Lilly from 1972 to 2026
LLY compared with Top 5 Most Popular stocks
Price of LLY Asset B Mkt. of B Results
Eli Lilly Eli Lilly
$4,229.11 $836.21B
$3.996T +377.84%
Eli Lilly Eli Lilly
$3,819.63 $836.21B
$3.609T +331.57%
Eli Lilly Eli Lilly
$3,477.98 $836.21B
$3.286T +292.97%
Eli Lilly Eli Lilly
$2,807.19 $836.21B
$2.652T +217.18%
Eli Lilly Eli Lilly
$2,272.83 $836.21B
$2.147T +156.80%